Complementary and alternative medicine

补充和替代医学
  • 文章类型: Journal Article
    许多功能失调性子宫出血(DUB)患者寻求传统医学咨询。本研究旨在调查台湾DUB患者的补充中草药(CHM)与手术率的关系。
    我们在1997年至2010年期间从台湾的国家健康保险研究数据库中招募了43,027名新诊断的DUB患者(ICD-9-CM代码626.8)。其中,38,324是CHM用户,4703没有接受CHM治疗。在根据患者年龄(每5岁)进行1:1的倾向评分匹配后,合并症,常规药物,分娩状态,从DUB的诊断年和指标年开始的持续时间,CHM队列和非CHM队列中的患者数量相等(n=4642).结果测量是手术事件发生率的比较,包括子宫切除术和子宫内膜切除术,在2013年底之前的两个队列中。
    CHM使用者的手术发生率低于非CHM使用者(调整后的HR0.27,95%CI:0.22-0.33)。在随访期间,CHM队列中手术的累积发生率显着降低(Log秩检验,p<0.001)。CHM队列中的146例患者(4.99/1000人年)和非CHM队列中的485例患者(20.19/1000人年)接受了手术(调整后的HR0.27,95%CI:0.22-0.33)。CHM还降低了有或没有合并症的DUB患者的手术风险。无论分娩状态或患者是否服用NSAIDs,氨甲环酸或孕酮,CHM队列中接受手术的患者少于非CHM队列.最常用的单一草药和配方是Yi-Mu-Cao(HerbaLeonuri)和Jia-Wei-Xiao-Yao-San,分别。
    真实世界数据显示,CHM与DUB患者手术率降低相关。这些信息可用于进一步的临床研究和政策制定。
    UNASSIGNED: Many patients with dysfunctional uterine bleeding (DUB) seek traditional medicine consultations. This study intended to investigate the association of complementary Chinese herbal medicine (CHM) with the surgery rate in patients with DUB in Taiwan.
    UNASSIGNED: We enrolled 43,027 patients with newly diagnosed DUB (ICD-9-CM codes 626.8) from the National Health Insurance Research Database in Taiwan during the period of 1997 to 2010. Among them, 38,324 were CHM users, and 4703 did not receive CHM treatment. After performing a 1:1 propensity-score match based on patients\' age (per 5 years), comorbidities, conventional drugs, childbirth status, duration from the diagnosis year of DUB and index year, there were an equal number (n=4642) of patients in the CHM cohort and non-CHM cohort. The outcome measurement was the comparison of incidences of surgical events, including hysterectomy and endometrial ablation, in the two cohorts before the end of 2013.
    UNASSIGNED: CHM users had a lower incidence of surgery than non-CHM users (adjusted HR 0.27, 95% CI: 0.22-0.33). The cumulative incidence of surgery was significantly lower in the CHM cohort during the follow-up period (Log rank test, p < 0.001). A total of 146 patients in the CHM cohort (4.99 per 1000 person-years) and 485 patients in the non-CHM cohort (20.19 per 1000 person-years) received surgery (adjusted HR 0.27, 95% CI: 0.22-0.33). CHM also reduced the risk of surgery in DUB patients with or without comorbidities. Regardless of childbirth status or whether patients took NSAIDs, tranexamic acid or progesterone, fewer patients in the CHM cohort underwent surgery than in the non-CHM cohort. The most commonly prescribed single herb and formula were Yi-Mu-Cao (Herba Leonuri) and Jia-Wei-Xiao-Yao-San, respectively.
    UNASSIGNED: The real-world data revealed that CHM is associated with a reduced surgery rate in DUB patients. This information may be provided for further clinical investigations and policy-making.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:抑郁症是一个主要的公共卫生问题。许多补充和替代医学(CAM)干预措施已被建议作为潜在的治疗方法。
    方法:我们在PubMed中全面搜索相关的系统综述和荟萃分析,EMBASE,WebofScience,和Cochrane图书馆数据库。我们根据抑郁评估量表评分的效率和变化评估有效性,并根据不良事件评估安全性。
    结果:这篇综述包括22篇符合条件的文章。月菊抗抑郁药和电针(EA)改善抑郁症状优于抗抑郁药。此外,ω-3脂肪酸(n-3PUFA),锻炼,手动针灸(MA),金丝桃单制剂,放松,维生素D的疗效优于安慰剂和对照组。GPD作为辅助治疗比抗抑郁药具有更高的疗效,MA和月菊抗抑郁药比抗抑郁药具有更好的安全性。
    结论:我们的研究表明,10种CAM可以有效改善临床抑郁症患者的病情。
    OBJECTIVE: Depression is a major public health problem. Many complementary and alternative medicine (CAM) interventions have been suggested as potential treatments.
    METHODS: We comprehensively searched for relevant systematic reviews and meta-analyses in the PubMed, EMBASE, Web of Science, and Cochrane Library databases. We assessed effectiveness based on efficiency and changes in Depression Assessment Scale scores and safety based on adverse events.
    RESULTS: This umbrella review included twenty-two eligible articles. Yueju antidepressant and Electro-acupuncture (EA) improved depression symptoms better than antidepressants. In addition, omega-3 fatty acids (n-3PUFAs), exercise, manual acupuncture (MA), Hypericum mono-preparations, relaxation, and Vitamin D showed better efficacy than placebo and control. GPD as adjunctive therapies have higher efficacy rates than antidepressant, and MA and Yueju antidepressants have a better safety profile than antidepressants.
    CONCLUSIONS: Our study demonstrated that 10 CAMs can effectively improve the condition of patients with clinical depression.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:补充和替代医学(CAM)的医学研究最近有所增加,引发了对CAM道德地位的伦理关注。医学学术期刊负责对手稿进行伦理审查(ER),以保护人类受试者的利益,并在决定发表之前提供伦理结果。然而,没有对CAM期刊中的ER进行系统分析。本研究旨在评估CAM期刊中道德要求和合规性的现状。
    方法:这是一项横断面研究。我们审查了期刊引文报告(2021)(https://jcr)中包含的CAM期刊作者(IFA)的说明。clarivate.com)获取ER的一般信息和要求。我们还浏览了CAM期刊在1月至6月Q1和Q2部分发表的随机对照试验的手稿,2023年,检查道德要求的实际情况。使用描述性统计和Fisher精确检验进行统计分析。
    结果:最终纳入了27种期刊和68份手稿。92.6%(25/27)的IFA包含ER的关键字,表明存在道德考虑。然而,CAM不需要特定的ER(n=0)。我们按地理来源对期刊进行分类,JCR部分,电子JCR年,研究的类型,%OAGold探讨可能影响CAM期刊制定一定伦理审查政策的因素。结果表明,在任何分类的期刊中,某些伦理审查政策均无统计学意义(p>0.05)。研究中包含的所有RCT手稿通常符合已发表期刊的伦理审查要求。
    结论:所有IFAs讨论的ER,但是内容是分散的,注意力不集中,并且没有关于CAM的特定ER要求。尽管手稿基本上符合期刊的要求,在手稿中不可能更接近ER的过程。为了确保这些政策在未来得到充分执行,CAM期刊应要求作者提供更多详细信息,或形成CAM伦理审查所需的项目清单。
    BACKGROUND: Medical research in complementary and alternative medicine (CAM) has increased recently, raising ethical concerns about the moral status of CAM. Medical academic journals are responsible for conducting ethical review (ER) of manuscripts to protect the interests of human subjects and to make ethical results available before deciding to publish. However, there has been no systematic analysis of the ER in CAM journals. This study is aim to evaluate the current status of ethical requirements and compliance in CAM journals.
    METHODS: This is a cross-sectional study. We reviewed instructions for authors (IFAs) of CAM journals included in the Journal Citation Reports (2021) ( https://jcr.clarivate.com ) for general information and requirements for ER. We also browsed the manuscripts regarding randomized controlled trials published by CAM journals in Q1 and Q2 section from January to June, 2023, to check the actual situation of ethical requirement. Descriptive statistics and Fisher\'s exact test were used for statistical analysis.
    RESULTS: 27 journals and 68 manuscripts were ultimately included. 92.6% (25/27) IFAs included keywords of ER, indicating the presence of ethical considerations. However, no specific ER was required for CAM (n = 0). We categorized journals by Geographic origin, JCR section, Year of electronic JCR, Types of studies, % of OA Gold to explore the factors that could influence CAM journals to have certain ethical review policies. The results showed there was no statistical significance in certain ethical review policy in any classification of journals (p > 0.05). All RCT manuscripts included in the study generally met the requirements of the published journals for ethical review.
    CONCLUSIONS: All IFAs discussed ER, but the content was scattered, unfocused, and there were no specific ER requirements regarding CAM. Although the manuscripts basically met the requirements of the journal, it was not possible to get closer to the process of ER in the manuscript. To ensure full implementation of these policies in the future, CAM journals should require authors to provide more details, or to form a list of items necessary for CAM ethical review.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:骨康胶囊已在中国用作治疗原发性骨质疏松症(POP)的补充和替代药物(CAM)。本研究的主要目的是评估骨康胶囊在POP患者中的临床有效性和安全性。方法:在包括PubMed在内的多个学术数据库中进行了系统的搜索,WebofScience,科克伦图书馆,中国国家知识基础设施,重庆贵宾信息,和万方数据库确定研究骨康胶囊治疗POP的随机对照试验。筛选过程,数据提取,方法质量评估由两名评审员独立进行。使用RevMan5.3软件进行统计分析。通过OPF的组合进行亚组分析。根据是否合并OPF进行亚组分析。Stata12.0用于敏感性和偏倚分析。结果:评估了19项研究,包括1804名参与者。结果发现,与对照组相比,总有效率(RR=1.26,95%CI,1.20,1.33),医学结果研究简表36[RR=1.26,95%CI(1.20,1.33)],腰椎骨密度(BMD)(SMD=0.77,95%CI,0.48,1.07),股骨颈骨密度[SMD=0.84,95%CI(0.53,1.14)],骨康胶囊实验组的沃德三角骨密度(SMD=0.64,95%CI,0.44,0.85)较高。与对照组相比,骨折愈合时间(SMD=-2.14,95%CI,-2.45,-1.84),血清中骨特异性碱性磷酸酶(BALP)水平(SMD=-2.00,95%CI,-2.83,-1.17),骨康胶囊实验组血清抗酒石酸酸性磷酸酶5b(TRACP-5b)水平(SMD=-2.58,95%CI,-3.87,-1.29)较低。试验组与对照组血清骨组织蛋白(BGP)水平(SMD=-0.22,95%CI,-1.86,1.43)及不良事件(RR=0.80,95%CI,0.40,1.63)无差异。结论:骨康胶囊,作为POP管理的CAM,展示了提高BMD和生活质量的潜力,加快OPF的愈合时间,降低BALP和TRACP-5b的水平,在不增加不良事件的情况下提高总有效率。系统审查注册:https://www。crd.约克。AC.uk/prospro/display_record.php?ID=CRD42023477774,PROSPEROCRD42023477774。
    Background: Gukang Capsule has been used as a complementary and alternative medicine (CAM) for the treatment of primary osteoporosis (POP) in China. The primary aim of this study was to assess the clinical effectiveness and safety of Gukang Capsule in POP patients. Methods: A systematic search was conducted across multiple academic databases including PubMed, Web of science, Cochrane Library, China National Knowledge Infrastructure, Chongqing VIP Information, and Wanfang database to identify randomized controlled trials investigating the Gukang Capsule in the treatment of POP. The screening process, data extraction, and assessment of methodological quality were conducted independently by two reviewers. Statistical analysis was performed using the Rev Man 5.3 software. Subgroup analysis was carried out through the combination of OPF. Subgroup analysis was performed according to whether OPF were combined. Stata 12.0 was used for sensitivity and bias analysis. Results: Nineteen studies were assessed that included 1804 participants. It was found that compared with the control group, the total effective rate (RR = 1.26, 95% CI, 1.20, 1.33), the Medical Outcomes Study Short-form 36 [RR = 1.26, 95% CI(1.20, 1.33)], the bone mineral density (BMD) of lumbar vertebra (SMD = 0.77, 95% CI, 0.48, 1.07), the BMD of femoral neck [SMD = 0.84, 95% CI(0.53, 1.14)], and the BMD of Ward\'s triangle (SMD = 0.64, 95% CI, 0.44, 0.85) of the Gukang Capsule experimental group were higher. Compared with the control group, the fracture healing time (SMD = -2.14, 95% CI, -2.45, -1.84), the bone specific alkaline phosphatase (BALP) levels in serum (SMD = -2.00, 95% CI, -2.83, -1.17), the tartrate resistant acid phosphatase 5b (TRACP-5b) levels in serum (SMD = -2.58, 95% CI, -3.87, -1.29) of the Gukang Capsule experimental group were lower. The bone glaprotein (BGP) levels in serum (SMD = -0.22, 95% CI, -1.86, 1.43) and the adverse events (RR = 0.80, 95% CI, 0.40, 1.63) of the experimental group and the control group have no difference. Conclusion: Gukang Capsule, as a CAM for the management of POP, exhibits the potential to enhance BMD and quality of life, expedite the healing time of OPF, diminish levels of BALP and TRACP-5b, and improve the total effective rate without increasing the adverse events. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023477774, PROSPERO CRD42023477774.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Editorial
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:紧张型头痛(TTH)很常见,但由于常规治疗的有效性有限,因此难以控制。本研究通过网络荟萃分析研究了六种补充和替代医学(CAM)干预措施,以确定有效的TTH管理策略。
    方法:我们搜索了PubMed,Embase,WebofScience,科克伦图书馆,OVID,CNKI,万方,VIP,和CBM数据库用于TTH治疗的CAM随机对照试验。头痛频率和强度是主要结果。基于Cochrane偏倚风险工具评估方法学质量。我们使用R软件进行了贝叶斯网络荟萃分析。我们使用具有95%可信间隔(CI)的平均差(MD)来计算连续结果,并分析了累积排名(SUCRA)曲线下的表面百分比。
    结果:总计,对32项随机对照试验(RCTs)进行分析,纳入2405名参与者。为了减轻头痛强度,网络荟萃分析表明,针灸疗法结合中药(AT_TCM),手动治疗(MT),心理治疗(PT),中医结合针灸和手法治疗(TCM_AT_MT)优于西医(WM)。在SUCRA曲线中,TCM_AT_MT是减少头痛频率(HF)的最佳选择。
    结论:这篇综述,按等级评估为低质量证据,谨慎地建议PT相对于其他CAM干预TTH的潜在益处,并表明TCM_AT_MT可能更好地降低HF。它建议将CAM干预措施结合起来可以增强结果。由于这些发现的初步性质,进一步的高质量RCT对于证实这些建议和提供更清晰的临床指导至关重要.
    CRD42021252073。
    BACKGROUND: Tension-type headache (TTH) is common but challenging to manage due to limited effectiveness of conventional treatments. This study examines six complementary and alternative medicine (CAM) interventions through network meta-analysis to identify effective TTH management strategies.
    METHODS: We searched PubMed, Embase, Web of Science, Cochrane Library, OVID, CNKI, Wanfang, VIP, and CBM databases for randomized controlled trials on CAM for TTH treatment. Headache frequency and intensity were the primary outcomes. Methodological quality was evaluated on the basis of the Cochrane risk of bias tool. We used R software to conduct this Bayesian network meta-analysis. We used mean difference (MD) with 95% credible intervals (CI) to calculate the continuous outcomes and analyzed the percentages of the surface under the cumulative ranking (SUCRA) curve.
    RESULTS: In total, 32 randomized controlled trials (RCTs) with 2405 participants were analyzed. For reducing headache intensity, the network meta-analysis shows that acupuncture therapy combined with traditional Chinese medicine (AT_TCM), manual therapy (MT), psychological treatment (PT), and traditional Chinese medicine combined with acupuncture and manual therapy (TCM_AT_MT) are superior to Western medicine (WM). In the SUCRA curve, TCM_AT_MT is the best for reducing headache frequency (HF).
    CONCLUSIONS: This review, assessed as low-quality evidence by GRADE, cautiously suggests potential benefits of PT over other CAM interventions for TTH and indicates TCM_AT_MT might better reduce HF. It proposes that combining CAM interventions could enhance outcomes. Due to the preliminary nature of these findings, further high-quality RCTs are essential to confirm these suggestions and provide clearer clinical guidance.
    UNASSIGNED: CRD42021252073.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    手稿的作者补充和替代医学-实践,态度,新西兰医疗保健专业人员的知识和知识:一项综合审查[1]不同意McDowell等人的主张。我们的手稿有推断错误。
    The authors of the manuscript \'Complementary and alternative medicine - practice, attitudes, and knowledge among healthcare professionals in New Zealand: an integrative review\' [1] disagree with the assertion by McDowell et al. that our manuscript has extrapolation errors.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究旨在评估单独使用仙灵骨葆(XLGB)胶囊及其联合疗法在原发性骨质疏松症(POP)中的疗效。
    包括PubMed、Embase,科克伦图书馆,WebofScience,CNKI,万方数据,VIP,和SinoMed从开始到2024年1月16日进行了随机对照试验(RCTs)研究,研究了XLGB治疗POP的方法.进行了网络荟萃分析(NMA)以评估多种干预措施在POP治疗中的有效性和安全性。使用Cochrane偏倚风险工具评估meta分析中纳入的RCT质量。Stata软件(15.0版)用于统计学分析。通过对多种干预措施进行排名,使用累积排名曲线(SUCRA)方法下的表面以数字和图形方式呈现该NMA的发现。
    共有107个随机对照试验纳入荟萃分析,涉及10032名参与者和21项干预措施。Meta分析显示,XLGB+钙(Ca)+降钙素(99.9%)是提高临床疗效的最理想治疗方案。XLGB+Ca+双膦酸盐(BP)对改善腰椎骨矿物质密度(BMD)最有效,股骨颈BMD,和血清骨Gla蛋白(BGP)。通过XLGBCaBP改善这三种结局指标的SUCRA值为87.4%,77.2%,和84.3%,分别。XLGB+降钙素是安全性评价和改善视觉模拟评分(VAS)的最佳选择。SUCRA值为89.6%和94.9%,分别。
    XLGB联合疗法是治疗POP的理想选择,因为它可以有效提高治疗效果,BMD,和血清BGP,以及减轻POP患者的疼痛。
    UNASSIGNED: This study aimed to evaluate the efficacy of the Xianling Gubao (XLGB) capsule alone and its combination therapy in primary osteoporosis (POP).
    UNASSIGNED: Databases including PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang Data, VIP, and SinoMed were searched from their inception to January 16, 2024, for randomized controlled trials (RCTs) investigating the XLGB treatment for POP. A network meta-analysis (NMA) was performed to evaluate the efficacy and safety of multiple interventions in the treatment of POP. The Cochrane risk-of-bias tool was used to assess the quality of RCTs included in the meta-analysis. Software Stata (version 15.0) was used for statistical analysis. The surface under the cumulative ranking curve (SUCRA) method was used to present the findings from this NMA numerically and graphically by ranking multiple interventions.
    UNASSIGNED: A total of 107 RCTs were included in the meta-analysis, involving 10,032 participants and 21 interventions. Meta-analysis showed that XLGB + calcium (Ca) + calcitonin (99.9 %) was the most desirable treatment option for improving clinical efficacy. XLGB + Ca + bisphosphonate (BP) was most effective for improving bone mineral density (BMD) at the lumbar spine, femoral neck BMD, and serum bone Gla protein (BGP). SUCRA values for improving these three outcome measures by XLGB + Ca + BP were 87.4 %, 77.2 %, and 84.3 %, respectively. XLGB + calcitonin was the optimal option in terms of safety evaluation and improving visual analogue scale (VAS), with the SUCRA values being 89.6 % and 94.9 %, respectively.
    UNASSIGNED: The XLGB combination therapy is a desirable option for treating POP as it can effectively improve the therapeutic effects, BMD, and serum BGP, as well as relieve pain in patients with POP.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    疫苗犹豫,被COVID-19大流行放大,是一项紧迫的公共卫生挑战。这项研究调查了中国传统中药(TCM)偏好与COVID-19疫苗犹豫之间的关系。
    该研究使用了2021年中国综合社会调查(CGSS)的数据(N=2690)。采用Logistic回归和Karlson-Holm-Breen(KHB)方法分析了中医偏好与疫苗犹豫之间的关系。
    该研究通过揭示中医偏好与疫苗犹豫之间的稳健和稳定关联来重申先前的发现,它仍然不受社会经济和人口混杂因素的影响,以及医疗系统的机构信任动态。与预期相反,与生物医学相比,基于对疫苗风险和免疫力获取的不同认识论观点,中医爱好者不会表现出疫苗犹豫。
    这项研究丰富了对医疗保健范式和疫苗态度之间复杂关系的理解,邀请进一步调查CAM在不同文化和环境中塑造疫苗接种行为的作用。这些见解对提高疫苗的接受度和覆盖率具有重大的公共卫生意义。特别是在CAM实践产生重大影响的人群中。
    Vaccine hesitancy, amplified by the COVID-19 pandemic, is a pressing public health challenge. This study investigates the association between Traditional Chinese Medicine (TCM) preference and COVID-19 vaccine hesitancy within China.
    The study uses data from the 2021 Chinese General Social Survey (CGSS) (N = 2,690). Logistic regressions and Karlson-Holm-Breen (KHB) method are employed to analyzed the relationship between TCM preference and vaccine hesitancy.
    The study reaffirms prior findings by revealing a robust and stable association between TCM preference and vaccine hesitancy, which remains unaffected by socioeconomic and demographic confounders, as well as institutional trust dynamics of healthcare system. Contrary to expectations, TCM enthusiasts do not exhibit vaccine hesitancy based on divergent epistemological views concerning vaccine risks and immunity acquisition compared to biomedicine.
    This research enriches understandings of the intricate relations between healthcare paradigms and vaccine attitudes, inviting further inquiry into the role of CAM in shaping vaccination behaviors across different cultures and contexts. The insights bear significant public health implications for enhancing vaccine acceptance and coverage, particularly among populations where CAM practices wield substantial influence.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    纤维肌痛(FM)是一种以广泛的骨骼肌疼痛为特征的普遍慢性病症。近年来,补充和替代医学(CAM)因其在治疗FM症状方面的潜力而越来越被认可。本研究旨在评估CAM疗法缓解FM症状的疗效。
    该系统评价已在INPLASY注册。从成立到2023年4月15日,对英文和中文数据库进行了彻底的搜索。搜索标准集中于前瞻性对照试验,以检查FM患者的CAM疗法。统计分析采用平均值和标准偏差。此外,对文献的质量和潜在偏差进行了评估。
    搜索产生了41篇文章,包括2877名FM患者,涉及20种不同的干预措施。所有研究均为随机对照试验(RCTs)。网络荟萃分析(NMA)的结果表明,针灸和按摩疗法相结合,以及肚脐针刺疗法,有效缓解FM患者的疼痛症状。此外,腹针和电针被发现有利于改善患者的情绪和睡眠质量。
    针灸+按摩和脐穴针法成为缓解FM患者疼痛症状的最有效疗法。腹针和电针证明了它们在提高情绪和睡眠质量方面的有效性。总的来说,CAM治疗对纤维肌痛患者具有很高的安全性。
    UNASSIGNED: Fibromyalgia (FM) is a prevalent chronic disorder characterized by widespread skeletal muscle pain. In recent years, complementary and alternative medicine (CAM) has increasingly been recognized for its potential in treating FM symptoms. This study aims to assess the efficacy of CAM therapies in mitigating the symptoms of FM.
    UNASSIGNED: This systematic review was registered with INPLASY. A thorough search of both English and Chinese databases was undertaken from their inception until April 15, 2023. The search criteria focused on prospective controlled trials examining CAM therapies in FM patients. The statistical analysis employed mean values and standard deviations. Additionally, an evaluation of the literature\'s quality and potential biases was conducted.
    UNASSIGNED: The search yielded 41 articles, encompassing 2877 FM patients and involving 20 different interventions. All studies were randomized controlled trials (RCTs). The results of the network meta-analysis (NMA) indicated that a combination of Acupuncture and Massage therapy, as well as Navel Needling therapy, effectively alleviated pain symptoms in FM patients. Furthermore, Abdominal Acupuncture and Electroacupuncture were found to be beneficial in improving patients\' mood and sleep quality.
    UNASSIGNED: Acupuncture + Massage and Umbilical Acupuncture emerged as the most efficacious therapies in relieving pain symptoms in FM patients. Abdominal Acupuncture and Electroacupuncture demonstrated their effectiveness in enhancing mood and sleep quality. Overall, CAM therapies exhibited a high safety profile for patients with fibromyalgia.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号